Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxifloxacin-induced QT Prolongation in Chinese vs. Caucasian Volunteers
NCT02119091Phase 1Unknown
- Start
- Apr 2014
- Primary completion
- Jun 2014
- Countries
- 2
01
Overview
Phase 1, randomised, double-blind trial of moxifloxacin in bacterial infection. Primary endpoint: Baseline-adjusted, placebo-corrected effect on QTcF at 2 months. Status: unknown.
02
Drugs
moxifloxacin
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT02119091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02119091.